Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma.
Cassaday RD, Press OW, Pagel JM, Rajendran JG, Gooley TA, Fisher DR, Holmberg LA, Miyaoka RS, Sandmaier BM, Green DJ, Gopal AK.
Cassaday RD, et al. Among authors: pagel jm.
Clin Cancer Res. 2019 Dec 1;25(23):6932-6938. doi: 10.1158/1078-0432.CCR-19-1567. Epub 2019 Sep 3.
Clin Cancer Res. 2019.
PMID: 31481510
Free PMC article.
Clinical Trial.